The Scotts Miracle-Gro Company (SMG) – What Are Analysts Thinking About This Stock?

The Scotts Miracle-Gro Company (NYSE:SMG – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven analysts that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $74.80.

SMG has been the topic of several analyst reports. Citigroup reissued an “overweight” rating on shares of Scotts Miracle-Gro in a research report on Monday, November 2nd. Weiss Ratings downgraded Scotts Miracle-Gro from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, October 6th. Wells Fargo & Company lifted their price target on Scotts Miracle-Gro from $71.00 to $76.00 and gave the company an “overweight” rating in a research note on Thursday, November 5th. JPMorgan Chase & Co. reduced their price target on shares of Scotts Miracle-Gro from $70.00 to $67.00 and set a “neutral” rating for the company in a research report on Thursday, November 5th. Finally, Stifel Nicolaus lowered their target price on Scotts Miracle-Gro from $76.00 to $75.00 and set a “buy” rating on the stock in a research note on Tuesday, September 29th.

Check Out Our Latest Analysis on SMG

Scotts Miracle-Gro Stock Up 2.5%

Shares of Scotts Miracle-Gro stock opened at $64.10 on Thursday. Scotts Miracle-Gro has a 52 week low of $47.90 and a 52 week high of $75.34. The stock’s fifty day moving average is $56.51 and its two-hundred day moving average is $61.99. The company has a market capitalization of $3.73 billion, a PE ratio of 38.16 and a beta of 1.87.

Scotts Miracle-Gro (NYSE:SMG – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The basic materials company reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.21) by $0.05. Scotts Miracle-Gro had a negative return on equity of 77.42% and a net margin of 3.16%. The firm had revenue of $302.90 million during the quarter, compared to analysts’ expectations of $306.11 million. During the same period last year, the business posted ($2.63) earnings per share. The company’s revenue for the quarter was down 10.9% compared to the same quarter last year. As a group, research analysts anticipate that Scotts Miracle-Gro will post 4.78 earnings per share for the current year.

Scotts Miracle-Gro Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Friday, November 20th. Scotts Miracle-Gro’s dividend payout ratio (DPR) is presently 157.14%.

Insider Transactions at Scotts Miracle-Gro

In related news, Director Peter Shumlin sold 3,716 shares of the company’s stock in a transaction dated Friday, November 13th. The shares were sold at an average price of $64.51, for a total transaction of $239,719.16. Following the completion of the transaction, the director owned 27,130 shares in the company, valued at $1,750,156.30. This represents a 12.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David Evans sold 2,655 shares of the business’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $66.42, for a total value of $176,345.10. Following the completion of the transaction, the director owned 25,405 shares in the company, valued at $1,687,400.10. This trade represents a 9.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 24.40% of the company’s stock.

Institutional Investors Weigh In On Scotts Miracle-Gro

A number of large investors have recently added to or reduced their stakes in SMG. Epoch Investment Partners Inc. purchased a new position in Scotts Miracle-Gro during the 1st quarter worth $50,058,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Scotts Miracle-Gro by 161.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 1,289,974 shares of the basic materials company’s stock worth $78,443,000 after buying an additional 795,970 shares in the last quarter. Edgestream Partners L.P. purchased a new position in Scotts Miracle-Gro in the 3rd quarter worth about $7,779,000. Advisors Asset Management Inc. purchased a new stake in shares of Scotts Miracle-Gro during the third quarter valued at $7,389,000. Finally, First Trust Advisors LP boosted its position in Scotts Miracle-Gro by 401.6% during the first quarter. First Trust Advisors LP now owns 153,678 shares of the basic materials company’s stock worth $9,345,000 after purchasing an additional 123,041 shares in the last quarter. Institutional investors and hedge funds own 74.07% of the company’s stock.

About Scotts Miracle-Gro

(Get Free Report)

Scotts Miracle-Gro Company develops, manufactures and markets branded products for lawn care and gardening. Its offerings include grass seed, lawn fertilizers and weed-control products, soils, plant foods and other products for growing and maintaining lawns, gardens and landscapes. Its consumer brands include Scotts, Miracle-Gro and Ortho. The company also has a Hawthorne business that supplies equipment and products for indoor and hydroponic gardening. Scotts Miracle-Gro’s products are sold primarily in North America, with additional operations and sales in international markets.

Read More

Analyst Recommendations for Scotts Miracle-Gro (NYSE:SMG)

Receive News & Ratings for Scotts Miracle-Gro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scotts Miracle-Gro and related companies with MarketBeat.com's FREE daily email newsletter.